Ducray

KERACNYL PP+ anti-blemish cream helps to reduce inflamed pimples. Its anti-blemish effectiveness is demonstrated after 7 days**. Prescribed by dermatologists, it compensates for dryness and flaking caused by medical treatments*** and soothes immediately. 24-hour hydration*. This non-greasy, non-sticky skin care product, suitable for adults and teenagers from the age of 12, also limits the appearance of marks. Benefit Promotes the disappearance of pimples after 7 days¹ and limits the appearance of marks. Soothes from the first application² • Acts on red pimples : the natural extract of MYRTACINE® helps to rebalance bacterial flora, CELASTROL® and VITAMIN PP help to reduce redness. • This treatment limits the appearance of marks and Soothes from the first application. • It helps to reduce feelings of discomfort caused by anti-acne medication. *IH kinetics, single application on 22 subjects **Clinical study conducted on 40 subjects. Twice-daily application for 8 weeks. ***Tolerance study in combination with topical treatments carried out on 39 subjects, aged between 12 and 40 years old. Study period (D1-D29) : 2 applications per day (morning and evening). Application 1 to 2 times a day Once or twice a day after cleansing with KERACNYL Foaming Gel Can be used alone or in combination with local drug treatment NON-COMEDOGENIC Designed to minimise the risk of allergic reactions Precaution to use : Avoid contact with eyes Myrtacine®: Active ingredient that helps fight the C. acnes bacteria by limiting its biofilm structure. Myrtacine soothes and corrects pimples. Celastrol: 1st innovative active ingredient from Pierre Fabre biotechnology, Celastrol, is of 100% natural origin and produced through the cultivation of plant cells. This soothing active ingredient directly targets keratinocytes to reduce the appearance of plaques and improve skin appearance Results • Effective after 7 days¹ • Skin is immediately soothed² : 96% • Anti-mark actions¹ ¹Clinical study conducted on 40 subjects. Twice-daily application for 8 weeks. ²Tolerance study in combination with topical treatments carried out on 39 subjects, aged between 12 and 40 years old. Study period (D1-D29) : 2 applications per day (morning and evening).